Table 3.

Profiles of probiotics after microfluidic assays and the corresponding NK activity change for each probiotic after six months.

Group category	Number	Occurrence percentage	Average increasing NK cytotoxicity	SD of NK cytotoxicity
IFN- γ	69	100%	6.3%	18.2%
B. longum BA100	1	1%	8.09%	None
E. faecium BR0085	2	3%	41.80%	None
L. reuteri BR101	0	0%	None	None
L. rhamnosus AD500	5	7%	9.60%	16.80%
L. acidophilus AD300	39	57%	4.34%	16.57%
L. paracasei BRAP01	22	32%	4.86%	18.30%
Group category	Number	Occurrence percentage	Average increasing NK cytotoxicity	SD of NK cytotoxicity
IL-10	21	100%	1.4%	13.6%
B. longum BA100	2	9%	−1.33%	None
E. faecium BR0085	6	29%	6.74%	7.90%
L. reuteri BR101	10	48%	1.58%	9.90%
L. rhamnosus AD500	3	14%	−7.66%	31.90%
L. acidophilus AD300	0	0%	0.00%	None
L. paracasei BRAP01	0	0%	0.00%	None